-
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH.
Am J Obstet Gynecol 2016;214:103.e1-103.e12 . pdf -
The use of ultrasound and other markers for early detection of preeclampsia.
O'Gorman N, Nicolaides KH, Poon LC.
Womens Health (Lond) 2016;12:199-207. pdf -
Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia.
Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:742-9. -
Maternal serum soluble adhesion molecule levels at 11+0-13+6 weeks and subsequent development of pre-eclampsia.
Parra-Cordero M, Turan OM, Kaur A, Pearson JD, Nicolaides KH.
J Matern Fetal Neonatal Med 2007;20:793-6. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Placental ABCA1 expression is reduced in primary antiphospholipid syndrome compared to pre-eclampsia and controls.
Albrecht C, Soumian S, Tetlow N, Patel P, Sullivan MH, Lakasing L, Nicolaides K, Williamson C.
Placenta 2007;28:701-8.